Prestige Consumer Healthcare Inc. (PBH)
NYSE: PBH · Real-Time Price · USD
43.11
-8.71 (-16.80%)
May 14, 2026, 9:45 AM EDT - Market open
PBH Revenue
In the fiscal year ending March 31, 2026, Prestige Consumer Healthcare had annual revenue of $1.09B, down -4.31%. Prestige Consumer Healthcare had revenue of $281.62M in the quarter ending March 31, 2026, a decrease of -5.03%.
Revenue (ttm)
$1.09B
Revenue Growth
-4.31%
P/S Ratio
2.25
Revenue / Employee
$1,814,508
Employees
600
Market Cap
2.04B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 1.09B | -49.05M | -4.31% |
| Mar 31, 2025 | 1.14B | 12.40M | 1.10% |
| Mar 31, 2024 | 1.13B | -2.37M | -0.21% |
| Mar 31, 2023 | 1.13B | 40.92M | 3.77% |
| Mar 31, 2022 | 1.09B | 143.45M | 15.21% |
| Mar 31, 2021 | 943.37M | -19.65M | -2.04% |
| Mar 31, 2020 | 963.01M | -12.77M | -1.31% |
| Mar 31, 2019 | 975.78M | -65.40M | -6.28% |
| Mar 31, 2018 | 1.04B | 159.12M | 18.04% |
| Mar 31, 2017 | 882.06M | 75.81M | 9.40% |
| Mar 31, 2016 | 806.25M | 91.62M | 12.82% |
| Mar 31, 2015 | 714.62M | 117.24M | 19.63% |
| Mar 31, 2014 | 597.38M | -22.74M | -3.67% |
| Mar 31, 2013 | 620.12M | 179.03M | 40.59% |
| Mar 31, 2012 | 441.09M | 104.58M | 31.08% |
| Mar 31, 2011 | 336.51M | 43.91M | 15.01% |
| Mar 31, 2010 | 292.60M | -1.74M | -0.59% |
| Mar 31, 2009 | 294.35M | -20.76M | -6.59% |
| Mar 31, 2008 | 315.11M | -3.53M | -1.11% |
| Mar 31, 2007 | 318.63M | 21.97M | 7.40% |
| Mar 31, 2006 | 296.67M | 7.60M | 2.63% |
| Mar 31, 2005 | 289.07M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Bausch Health Companies | 10.53B |
| Perrigo Company | 4.18B |
| Amneal Pharmaceuticals | 3.05B |
| Phibro Animal Health | 1.50B |
| ANI Pharmaceuticals | 923.71M |
| BioCryst Pharmaceuticals | 885.72M |
| Supernus Pharmaceuticals | 776.83M |
| Kiniksa Pharmaceuticals International, | 754.05M |
PBH News
- 4 hours ago - Prestige Consumer downgraded to Perform from Outperform at Oppenheimer - TheFly
- 17 hours ago - Prestige Consumer Healthcare Inc. Reports Fiscal 2026 Results, Announces Acquisition of LaCorium Health - GlobeNewsWire
- 6 days ago - Prestige Consumer price target lowered to $65 from $77 at Oppenheimer - TheFly
- 14 days ago - Prestige Consumer Healthcare to Release Fiscal 2026 Fourth Quarter and Year-End Earnings Results - GlobeNewsWire
- 7 weeks ago - Prestige Consumer Healthcare to Buy Breathe Right, Other Brands for $1.045 Billion - WSJ
- 7 weeks ago - Prestige Consumer Healthcare Transcript: M&A announcement - Transcripts
- 7 weeks ago - Prestige Consumer to acquire Breathe Right, other brands for $1.045B - TheFly
- 7 weeks ago - Prestige Consumer Healthcare Announces Agreement to Acquire Breathe Right®, the Leader in Nasal Strips - GlobeNewsWire